Effects of neuropeptide Y2 receptor blockade on ventricular arrhythmias in rats with acute myocardial infarction

European Journal of Pharmacology

Volumn 565, Issue 1-3, 2007, Pages 138-143

  Omerovic, Elmir ^a   Råmunddal, Truls ^a   Lorentzon, Malin ^a   Nordlander, Margareta ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Arrhythmias; Heart failure; Myocardial infarction; Myocardial ischemia; Neuropeptide Y; Sympathicus; Vagus

Indexed keywords

AMIODARONE; ARH 053591; N2 [2 (1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 3H 1,2,4 TRIAZOL 4 YL)ETHYL]ARGININAMIDE; NEUROPEPTIDE Y2 RECEPTOR; RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; NEUROPEPTIDE Y RECEPTOR;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRESSLER SYNDROME; ELECTROCARDIOGRAM; GUINEA PIG; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; LEFT CORONARY ARTERY; LIGATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SCORING SYSTEM; SPRAGUE DAWLEY RAT; SUDDEN DEATH; SYMPATHETIC TONE; TELEMETRY; VAGUS TONE; ANIMAL; DRUG ANTAGONISM; HEART ARRHYTHMIA; HEART INFARCTION; PHYSIOLOGY;

ANIMALS; ARRHYTHMIA; GUINEA PIGS; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y;

EID: 34249055238     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.03.002     Document Type: Article

References (29)

1. Anderson K.P. Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. Ann. Noninvasive Electrocardiol. 8 (2003) 75-89
2. Barron H.V., and Lesh M.D. Autonomic nervous system and sudden cardiac death. J. Am. Coll. Cardiol. 27 (1996) 1053-1060
3. Chronwall B.M., and Zukowska Z. Neuropeptide Y, ubiquitous and elusive. Peptides 25 (2004) 359-363
4. Curtis M.J., and Walker M.J. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc. Res. 22 (1988) 656-665
5. De Ferrari G.M., Vanoli E., Stramba-Badiale M., Hull Jr. S.S., Foreman R.D., and Schwartz P.J. Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am. J. Physiol. 261 (1991) H63-H69
6. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., and Rudolf K. BIIE0246: a selective and high-affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol. 384 (1999) R3-R5
7. Haverkamp W., Gulker H., Hindricks G., and Breithardt G. Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications. Basic Res. Cardiol. 85 Suppl 1 (1990) 293-303
8. Haverkamp W., Hindricks G., and Gulker H. Antiarrhythmic properties of beta-blockers. J. Cardiovasc. Pharmacol. 16 Suppl 5 (1990) S29-S32
9. Hoover D.B., Ganote C.E., Ferguson S.M., Blakely R.D., and Parsons R.L. Localization of cholinergic innervation in guinea pig heart by immunohistochemistry for high-affinity choline transporters. Cardiovasc. Res. 62 (2004) 112-121
10. Huang T.F. Drug effects on the ischemia- and reperfusion-induced arrhythmias in the conscious rats. Chin. J. Physiol. 35 (1992) 9-19
11. Johnston K.M., MacLeod B.A., and Walker M.J. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can. J. Physiol. Pharm. 61 (1983) 1340-1353
12. Kawada T., Yamazaki T., Akiyama T., Mori H., Uemura K., Miyamoto T., Sugimachi M., and Sunagawa K. Disruption of vagal efferent axon and nerve terminal function in the postischemic myocardium. Am. J. Physiol. 283 (2002) H2687-H2691
13. Meesmann M., Karagueuzian H.S., Ino T., McGrath M.F., and Mandel W.J. The role of enhanced vagal activity on ischemic ventricular tachycardia: pharmacologic basis of inefficiency. Am. Heart J. 121 (1991) 1703-1713
14. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 85 (1992) I2-I10
15. Niroomand F., Weinbrenner C., Weis A., Bangert M., Schwencke C., Marquetant R., Beyer T., Strasser R.H., Kubler W., and Rauch B. Impaired function of inhibitory G-proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia. Possible implications for the protective mechanism of ischemic preconditioning. Circ. Res. 76 (1995) 861-870
16. Omerovic E., Bollano E., Madhu B., Kujacic V., Waagstein L., Hjalmarson A., Waagstein F., and Soussi B. Bioenergetic, functional and morphologic consequences of postinfarct cardiac remodeling in the rat. J. Mol. Cell. Cardiol. 31 (1999) 1685-1695
17. Opitz C.F., Mitchell G.F., Pfeffer M.A., and Pfeffer J.M. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92 (1995) 253-261
18. Opitz C.F., Finn P.V., Pfeffer M.A., Mitchell G.F., and Pfeffer J.M. Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage. J. Am. Coll. Cardiol. 32 (1998) 261-267
19. Packer M. Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failure. Circulation 82 (1990) I77-I88
20. Packer M. Beta-adrenergic blockade in chronic heart failure: principles, progress, and practice. Prog. Cardiovasc. Dis. 41 (1998) 39-52
21. Pell S., and Fayerweather W.E. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population, 1957-1983. N. Engl. J. Med. 312 (1985) 1005-1011
22. Podrid P.J., Fuchs T., and Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 82 (1990) I103-I113
23. Schomig A. Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation 82 (1990) II13-II22
24. Schomig A., Haass M., and Richardt G. Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur. Heart J. 12 Suppl F (1991) 38-47
25. Schwertfeger E., Klein T., Vonend O., Oberhauser V., Stegbauer J., and Rump L.C. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y(2)-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 369 (2004) 455-461
26. Smith-White M.A., Herzog H., and Potter E.K. Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission. Regul. Pept. 103 (2002) 105-111
27. Strasser R.H., Marquetant R., and Kubler W. Adrenergic receptors and sensitization of adenylyl-cyclase in acute myocardial ischemia. Circulation 82 (1990) II23-II29
28. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W., et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
29. Vanoli E., De Ferrari G.M., Stramba-Badiale M., Hull Jr. S.S., Foreman R.D., and Schwartz P.J. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ. Res. 68 (1991) 1471-1481